Livzon Pharmaceutical Group Inc.’s Net Profit Rose 2.2% in First Quarter of 2022

Livzon Pharmaceutical Group Inc. (丽珠医药集团股份有限公司) (000513.SZ) reported a net profit of 611.1 million yuan in the first quarter of 2022, up 2.2% year-on-year.

Meanwhile, the company posted 3.5 billion yuan in revenue, up 3.9% year-on-year.

At the end of the reporting period, it had 23.7 billion yuan in total assets and 8.8 billion yuan in total liabilities, with a liability-to-asset ratio of 37.1%.